Semaglutide and tirzepatide are the most widely used GLP-1 agonists for weight loss and are approved for chronic management, not short-term use
Kathleen Valenton, board-certified physician and Chief Medical Officer at Lemme, who points out that most people who stop taking their meds regain weight
The eyes have it: Reasons you should avoid color-changing eye drops October 28, 2024 Fads tend to change in the blink of an eye
Addiction treatment approaches must be carefully tailored
Hers weight loss membership starts at just $39 for the first month How does Hers work
(Mounjaro is an injectable medication FDA-approved to help treat type 2 diabetes, but is it also often prescribed off-label to aid with weight loss.) At first, I was skeptical of the long-term results, side effects, and potential risks, and questioned whether the medication was regulated for non-diabetics